| Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors S Pandey, P Kumari, M Baidya, R Kise, Y Cao, H Dwivedi-Agnihotri, ... Molecular cell 81 (22), 4605-4621. e11, 2021 | 93 | 2021 |
| CD8+ lineage dendritic cells determine adaptive immune responses to inflammasome activation upon sterile skin injury R Chakraborty, J Chandra, S Cui, L Tolley, MA Cooper, M Kendall, ... Experimental Dermatology 27 (1), 71-79, 2018 | 13 | 2018 |
| Development of potent and selective agonists for complement C5a receptor 1 with in vivo activity DM Gorman, XX Li, JD Lee, JN Fung, CS Cui, HS Lee, BE Rolfe, ... Journal of Medicinal Chemistry 64 (22), 16598-16608, 2021 | 11 | 2021 |
| Optimisation of a Microfluidic Method for the Delivery of a Small Peptide FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ... Pharmaceutics 13 (9), 1505, 2021 | 6 | 2021 |
| Success in navigating hurdles to oral delivery of a bioactive peptide complement antagonist through use of nanoparticles to increase bioavailability and in vivo efficacy W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ... Advanced Therapeutics 5 (12), 2200109, 2022 | 5 | 2022 |
| In vivo pharmacodynamic method to assess complement C5a receptor antagonist efficacy CS Cui, V Kumar, DM Gorman, RJ Clark, JD Lee, TM Woodruff ACS Pharmacology & Translational Science 5 (1), 41-51, 2021 | 4 | 2021 |
| Development of Synthetic Human and Mouse C5a: Application to Binding and Functional Assays In Vitro and In Vivo DM Gorman, XX Li, CD Payne, CS Cui, JD Lee, KJ Rosengren, ... ACS Pharmacology & Translational Science 4 (6), 1808-1817, 2021 | 4 | 2021 |
| Sustained-release ketamine-loaded lipid-particulate system: in vivo assessment in mice W Xu, F Maqbool, V Kumar, JR Falconer, CS Cui, TM Woodruff, K Borges, ... Drug Delivery and Translational Research, 1-9, 2022 | 1 | 2022 |
| Metabolic rate and insulin-independent glucose uptake increase in a TDP-43Q331K mouse model of amyotrophic lateral sclerosis. TS McDonald, CS Cui, T Lerskiatiphanich, J Marallag, JD Lee Heliyon, 2025 | | 2025 |
| SpaMTP: Integrative Statistical Analysis and Visualisation of Spatial Metabolomics and Transcriptomics data A Causer, T Lu, C Fitzgerald, A Newman, H Vu, X Tan, T Vo, C Cui, ... bioRxiv, 2024.10. 31.621429, 2024 | | 2024 |
| Colon-targeted complement C5aR1 inhibition using pH-sensitive nanoparticles ameliorates experimental colitis C Cui, J Lee, T Woodruff European Journal of Immunology 54, 28-28, 2024 | | 2024 |
| Development of novel peptide ligands with improved selectivity and pharmacological properties for complement system receptors R Clark, D Gorman, X Li, J Dent, C Cui, HS Lee, J Fung, J Lee, ... Journal of Peptide Science 30, 2024 | | 2024 |
| Success in Navigating Hurdles to Oral Delivery of a Bioactive Peptide Complement Antagonist through Use of Nanoparticles to Increase Bioavailability and In Vivo Efficacy (Adv … W Xu, V Kumar, CS Cui, XX Li, AK Whittaker, ZP Xu, MT Smith, ... Advanced Therapeutics 5 (12), 2270030, 2022 | | 2022 |
| An in-vivo pharmacodynamic method to investigate complement C5a receptor antagonists C Cui, V Kumar, D Gorman, R Clark, J Lee, T Woodruff MOLECULAR IMMUNOLOGY 141, 125-126, 2022 | | 2022 |
| Optimisation of a Microfluidic Method for the Delivery of a Small Peptide. Pharmaceutics 2021, 13, 1505 FY Han, W Xu, V Kumar, CS Cui, X Li, X Jiang, TM Woodruff, AK Whittaker, ... Nanomedicine Formulations Based on PLGA Nanoparticles for Diagnosis …, 2021 | | 2021 |
Trent M. WoodruffProfessor, The University of QueenslandПотвърден имейл адрес: uq.edu.au